Resumption of Sexual Intercourse in the Postpartum Period: Women's Experiences (RS-PP)

February 24, 2026 updated by: Université de Reims Champagne-Ardenne

Sexual health, according to the World Health Organization (WHO), is a state of overall well-being related to sexuality. In the postpartum period, sexual health is often affected by hormonal, physical, and psychological changes. Up to 83% of women report sexual difficulties within the first three months after childbirth, and these issues may persist for up to a year. Dyspareunia is one of the most common symptoms, affecting approximately 35% of postpartum women. Other difficulties include vaginal dryness, fatigue, decreased libido, and fear of pain. Breastfeeding and perineal trauma are known to influence the resumption of sexual activity.

Health professionals may lack training or confidence in addressing sexual health, often leaving women to cope with their difficulties alone, even though they express a need for information and support. In this context, it is essential to better understand the difficulties women face when resuming sexual activity after childbirth, in order to improve the detection and management of sexual health disorders.

Study Overview

Status

Completed

Conditions

Intervention / Treatment

Detailed Description

Objectives Primary: To describe the resumption of sexual activity within the first 3 months postpartum, including any potential difficulties encountered.

Study Type

Observational

Enrollment (Actual)

80

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

  • France
      • Reims, France, 51100
        • Ufr Medecine Urca

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult
  • Older Adult

Accepts Healthy Volunteers

Yes

Sampling Method

Non-Probability Sample

Study Population

women aged 18 and over, with a partner who gave birth more than 3 months and less than 6 months ago, regardless of the mode of delivery, whether or not they have resumed sexual intercourse since giving birth

Description

Inclusion Criteria:

  • Women who gave birth between 3 and 6 months prior to participating in the study
  • Whether or not they have resumed sexual intercourse.
  • With a partner.
  • Aged 18 years or older
  • Agreeing to participate in the study.

Exclusion Criteria:

  • Women who were pregnant at the time of the study
  • Who had experienced perinatal bereavement
  • Who were protected by law (guardianship, curatorship, judicial protection)

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Questionnaire on the resumption of sexual intercourse in the postpartum period
Time Frame: Day0
Proportion of participants who resumed sexual intercourse within the 3 months following childbirth
Day0

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Université de Reims Champagne-Ardenne

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

November 22, 2025

Primary Completion (Actual)

January 22, 2026

Study Completion (Actual)

January 22, 2026

Study Registration Dates

First Submitted

February 12, 2026

First Submitted That Met QC Criteria

February 24, 2026

First Posted (Actual)

February 27, 2026

Study Record Updates

Last Update Posted (Actual)

February 27, 2026

Last Update Submitted That Met QC Criteria

February 24, 2026

Last Verified

February 1, 2026

More Information

Terms related to this study

Keywords

Additional Relevant MeSH Terms

Other Study ID Numbers

  • 2025_RIPH_11_SF_N Painvin

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

UNDECIDED

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Sexual Intercourse

Clinical Trials on data collection

Search Similar Trials

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Chile

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations

Subscribe